Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -90.49% is 34% above its 5-year average of -137.94%, near the high end of its 5-year range (-243.08%–-66.97%).
6.62% below its 12-month average of -84.87%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -82.92%.
OPERATING MARGIN
-90.49%
OPERATING MARGIN AVG TTM
-84.87%
OPERATING MARGIN AVG 3Y
-92.97%
OPERATING MARGIN AVG 5Y
-137.94%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.62%
CURRENT VS 3Y AVG
+2.66%
CURRENT VS 5Y AVG
+34.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CVRx, Inc.
Market Cap
$41.92M
Operating Margin
-90.49%
TTM Avg
-84.87%
3Y Avg
-92.97%
5Y Avg
-137.94%
Market Cap
$41.90M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$40.28M
Operating Margin
-380.85%
TTM Avg
-275.43%
3Y Avg
-246.44%
5Y Avg
-2168.10%
Market Cap
$44.16M
Operating Margin
-1.45%
TTM Avg
4.45%
3Y Avg
-26.46%
5Y Avg
-35.98%
Market Cap
$44.20M
Operating Margin
-466.16%
TTM Avg
-484.55%
3Y Avg
-719.99%
5Y Avg
-1266.78%
Market Cap
$39.23M
Operating Margin
0.00%
TTM Avg
-13830.82%
3Y Avg
-69500.82%
5Y Avg
-46675.05%
Market Cap
$39.21M
Operating Margin
7.92%
TTM Avg
3.07%
3Y Avg
-12.13%
5Y Avg
-21.71%
Market Cap
$44.81M
Operating Margin
0.00%
TTM Avg
-1952.10%
3Y Avg
-1112.27%
5Y Avg
-741.51%
Market Cap
$38.52M
Operating Margin
1.17%
TTM Avg
-3.67%
3Y Avg
-2.94%
5Y Avg
-1.63%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $41.92M | -90.49% | -84.87% | -92.97% | -137.94% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -380.85% | -275.43% | -246.44% | -2168.10% |
| BioStem Technologies, Inc. (BSEM)vs › | $44.16M | -1.45% | 4.45% | -26.46% | -35.98% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.20M | -466.16% | -484.55% | -719.99% | -1266.78% |
| Incannex Healthcare Limited (IXHL)vs › | $39.23M | 0.00% | -13830.82% | -69500.82% | -46675.05% |
| Nephros, Inc. (NEPH)vs › | $39.21M | 7.92% | 3.07% | -12.13% | -21.71% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.81M | 0.00% | -1952.10% | -1112.27% | -741.51% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | 1.17% | -3.67% | -2.94% | -1.63% |
| DarioHealth Corp. (DRIO)vs › | $45.37M | -163.94% | -188.75% | -214.75% | -271.10% |
Gross Margin
86.6%
Operating Margin
-90.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -82.92% |
| 2026-03-31 | -82.34% |
| 2025-12-31 | -69.80% |
| 2025-09-30 | -83.51% |
| 2025-06-30 | -105.79% |
| 2025-03-31 | -108.82% |
| 2024-12-31 | -66.97% |
| 2024-09-30 | -97.29% |
| 2024-06-30 | -118.35% |
| 2024-03-31 | -206.43% |
| 2023-12-31 | -85.46% |
| 2023-09-30 | -90.65% |
| 2023-06-30 | -123.71% |
| 2023-03-31 | -152.43% |
| 2022-12-31 | -159.96% |
| 2022-09-30 | -163.69% |
| 2022-06-30 | -218.92% |
| 2022-03-31 | -243.08% |
| 2021-12-31 | -240.24% |
| 2021-09-30 | -214.76% |
| 2021-06-30 | -181.62% |
| 2021-03-31 | -147.45% |
| 2020-12-31 | -102.25% |
| 2020-09-30 | -305.12% |
| 2020-06-30 | -244.80% |
| 2020-03-31 | -190.75% |
